nifedipine has been researched along with cardiovascular agents in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (31.25) | 18.7374 |
1990's | 15 (46.88) | 18.2507 |
2000's | 5 (15.63) | 29.6817 |
2010's | 2 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budriesi, R; Chiarini, A; Fruttero, R; Gasco, A; Gasco, AM; Sorba, G | 1 |
Adachi, H; Kodama, K; Ogawa, T; Ohhara, H | 1 |
Cooke, ED; Nicolaides, AN | 1 |
Eberlein, W; Heider, J; Kobinger, W; Lillie, C; Luger, P; Müller, P; Noll, K; Psiorz, M; Reiffen, M | 1 |
Beckeringh, JJ; Hendriks, MG; Hugtenburg, JG; Mathy, MJ; Van Marle, J; Van Veen, HA; Van Voorst, MJ; Van Zwieten, PA | 1 |
Ioannou, P; Talesnik, J | 1 |
Imhof, PR; Keller, R; Müller, P | 1 |
Dubur, GJ; Gendvilienè, VI; Kimenis, AA; Macianskiene, RA; Narusevicius, EV; Selga, MJ; Simkhovich, BZ; Velena, AH; Vitolina, RO; Zarinsh, GV | 1 |
Arakawa, K; Hiroki, T; Kumagai, S; Moriyama, Y; Mutaguchi, T; Shindo, M; Tanaka, H; Yoshida, T | 1 |
Al'perovich, BR; Kukes, VG; Rumiantsev, AS | 1 |
Bochkareva, EV; Kokurina, EV; Martsevich, SIu; Shakarova, SSh; Vygodin, VA | 1 |
Batenhorst, RL; Bottorff, MB; Foster, TS; Graves, DA; McAllister, RG | 1 |
Zelis, RF | 1 |
Anders, G; Brachmann, J; Hamman, HD; Jauernig, R; Kübler, W; Rizos, I; Senges, J | 1 |
Sanchez-Cascos, A | 1 |
Baiker, WM; Frishman, WH; Pepine, CJ; Weiss, RJ | 1 |
Bretnall, AE; Clarke, GS | 1 |
Franceschini, G; Sirtori, CR | 1 |
Dubray, C; Francheteau, P; Guerret, M; Merdjan, H; Steimer, JL | 1 |
Naumov, VG; Naumova, NA; Shkarin, VV | 1 |
Dong, H; Lee, CM; Sheng, JZ; Wong, TM | 1 |
Churshin, AD; Ezhov, AV; Pimenov, LT | 1 |
Choate, JK; Paterson, DJ; Sears, CE | 1 |
Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG | 1 |
Chuliá, S; D'Ocon, MP; Ivorra, MD; Noguera, MA | 1 |
Higuchi, H; Katsumata1, N; Ma, X | 1 |
Aminabhavi, TM; Kulkarni, AR; Soppimath, KS | 1 |
Chiou, SY; Lai, GW; Lin, G; Lin, LY | 1 |
Assreuy, AM; Criddle, DN; de Freitas Pires, A; Lima, RF; Soares, PM; Souza, EP | 1 |
Colino, A; Halliwell, JV; Sánchez-Alonso, JL | 1 |
Araki, E; Fukuda, K; Ishii, N; Kawada, T; Kim-Mitsuyama, S; Kinoshita, H; Matsumura, T; Miyamura, N; Motoshima, H; Nakao, S; Nishikawa, T; Senokuchi, T; Takeya, M; Tsutsumi, A | 1 |
Gil Cunquero, JM; Gutiérrez Rivas, PC; Liébana Cañada, A; Merino García, E; Viñolo López, MC | 1 |
1 review(s) available for nifedipine and cardiovascular agents
Article | Year |
---|---|
Raynaud's syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Epoprostenol; Female; Humans; Iloprost; Moxisylyte; Nifedipine; Raynaud Disease | 1990 |
5 trial(s) available for nifedipine and cardiovascular agents
Article | Year |
---|---|
Pharmacological profiling of cardiovascular agents in healthy volunteers by means of non-invasive methods.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Angiotensin II; Blood Pressure; Cardiography, Impedance; Cardiovascular Agents; Furosemide; Heart Rate; Humans; Male; Nifedipine; Nitroglycerin; Phentolamine; Systole | 1987 |
[Ergometric evaluation of corinfar, phenoptin, obsidan and 2% nitroglycerin ointment in exercise-induced stenocardia].
Topics: Adult; Angina Pectoris; Cardiovascular Agents; Clinical Trials as Topic; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Nitroglycerin; Ointments; Propranolol; Vasodilator Agents; Verapamil | 1985 |
Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzazepines; Blood Pressure; Cardiovascular Agents; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Treatment Outcome | 1995 |
[The prognosis of the antianginal effect of foridon compared to other antianginal preparations].
Topics: Angina Pectoris; Blood Pressure; Cardiovascular Agents; Echocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Prognosis; Respiratory Function Tests | 1993 |
[Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
Topics: Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Diltiazem; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Outpatients; Vasodilator Agents; Verapamil | 1995 |
26 other study(ies) available for nifedipine and cardiovascular agents
Article | Year |
---|---|
Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Cardiovascular Agents; Dihydropyridines; Female; Guinea Pigs; Heart Rate; Heterocyclic Compounds; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine | 1992 |
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs.
Topics: Anesthesia; Animals; Benzopyrans; Cardiovascular Agents; Catechols; Clonidine; Coronary Vessels; Cromakalim; Electrocardiography; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isosorbide Dinitrate; Male; Nifedipine; Pyrroles; Vasodilator Agents; Vasopressins | 1992 |
Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties.
Topics: Animals; Anti-Arrhythmia Agents; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Chemical Phenomena; Chemistry; Coronary Disease; Guinea Pigs; Heart Rate; Isoindoles; Molecular Conformation; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Phthalimides; Rabbits; Rats; Structure-Activity Relationship; Verapamil | 1990 |
The influence of nifedipine and mioflazine on mitochondrial calcium overload in normoxic and ischaemic guinea-pig hearts.
Topics: Animals; Antimony; Calcium; Cardiovascular Agents; Coronary Disease; Guinea Pigs; Homeostasis; In Vitro Techniques; Mitochondria, Heart; Myocardial Reperfusion; Nifedipine; Oxalates; Piperazines | 1990 |
Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Agents; Coronary Circulation; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Hydralazine; Iloprost; In Vitro Techniques; Male; Nifedipine; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasoconstriction | 1986 |
Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anura; Calcium Channel Blockers; Cardiovascular Agents; Cattle; Dihydropyridines; Electric Stimulation; Electrophysiology; Heart; In Vitro Techniques; Mitochondria; Mitochondria, Liver; Mitochondrial Swelling; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Nicardipine; Nifedipine; Pyridines; Rabbits; Rats | 1985 |
Effect of nifedipine, dilazep, dinitrates and propranolol on blood lactate accumulation during intensive graded exercise testing in healthy young subjects.
Topics: Adult; Blood Pressure; Cardiovascular Agents; Dilazep; Exercise Test; Heart Rate; Humans; Lactates; Lactic Acid; Nifedipine; Nitrates; Propranolol | 1988 |
[Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
Topics: Angina Pectoris; Cardiovascular Agents; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Physical Endurance; Propranolol | 1985 |
Nifedipine stability in cardioplegic solution.
Topics: Cardiovascular Agents; Drug Stability; Heart Arrest, Induced; Light; Nifedipine; Photochemistry; Polyvinyl Chloride; Solutions | 1984 |
Calcium entry blockers in cardiologic therapy.
Topics: Angina Pectoris, Variant; Calcium; Cardiovascular Agents; Diltiazem; Heart Diseases; Hemodynamics; Humans; Models, Biological; Muscle, Smooth, Vascular; Nifedipine; Vasoconstriction; Verapamil | 1981 |
Effect of nifedipine and AQ-A 39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia.
Topics: Action Potentials; Animals; Atrioventricular Node; Cardiovascular Agents; Heart Conduction System; Isoindoles; Nifedipine; Phthalimides; Pyridines; Rabbits; Sinoatrial Node; Tachycardia | 1983 |
Evaluation of effect of drugs on the exercise ECG.
Topics: Atenolol; Blood Pressure; Cardiovascular Agents; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Propranolol; Verapamil | 1981 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
[Pharmacological control of heart rate].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Animals; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiovascular Agents; Coronary Circulation; Dihydropyridines; Electrocardiography; Female; Heart Rate; Humans; In Vitro Techniques; Male; Middle Aged; Nifedipine; Population Surveillance; Rabbits; Sinoatrial Node; Tachycardia; Verapamil | 1994 |
A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers.
Topics: Adult; Baroreflex; Blood Pressure; Cardiac Output; Cardiovascular Agents; Dihydropyridines; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Models, Theoretical; Nicardipine; Nifedipine; Pressoreceptors; Retrospective Studies; Vascular Resistance | 1993 |
Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
Topics: Action Potentials; Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vessels; Diltiazem; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoquinolines; Male; Myocardial Contraction; Myocardium; Nifedipine; Papillary Muscles; Piperidines; Potassium Chloride; Rabbits; Rats; Rats, Sprague-Dawley; Sinoatrial Node; Tetrahydroisoquinolines | 1993 |
Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Arginine; Calcium Channel Blockers; Cardiovascular Agents; Cesium; Electric Stimulation; Enzyme Inhibitors; Guinea Pigs; Heart Atria; Heart Rate; Male; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pyrimidines; Vagus Nerve | 1998 |
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1999 |
Effect of divalent cations on KCl- and noradrenaline-induced contractile responses in rat aorta after nifedipine treatment.
Topics: Animals; Aorta, Thoracic; Calcium; Cardiovascular Agents; Cations, Divalent; In Vitro Techniques; Isotonic Solutions; Male; Nifedipine; Norepinephrine; Potassium Chloride; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Protective effect of diltiazem against ischemia-induced decreases in regional myocardial flow in rat heart.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Coronary Circulation; Diltiazem; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Injections; Male; Microspheres; Myocardial Ischemia; Nifedipine; Rats; Rats, Wistar; Regional Blood Flow; Time Factors | 2000 |
Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics.
Topics: Algorithms; Antihypertensive Agents; Calorimetry, Differential Scanning; Cardiovascular Agents; Delayed-Action Preparations; Diffusion; Half-Life; Kinetics; Microscopy, Electron, Scanning; Microspheres; Nicardipine; Nifedipine; Particle Size; Solubility | 2001 |
Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro.
Topics: Amlodipine; Cardiovascular Agents; Enzyme Inhibitors; Hydralazine; Kinetics; Nifedipine; Octoxynol; Simvastatin; Sterol Esterase; Taurocholic Acid | 2006 |
Effects of anethole and structural analogues on the contractility of rat isolated aorta: Involvement of voltage-dependent Ca2+-channels.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Aorta; Calcium; Calcium Channels; Cardiovascular Agents; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavoring Agents; Indomethacin; Male; Muscle Contraction; Muscle Relaxation; Muscle Tonus; NG-Nitroarginine Methyl Ester; Nifedipine; Organ Culture Techniques; Oxidants; Phenylephrine; Rats; Rats, Wistar; Structure-Activity Relationship; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |
ZD 7288 inhibits T-type calcium current in rat hippocampal pyramidal cells.
Topics: Animals; Animals, Newborn; Calcium Channel Blockers; Calcium Channels, T-Type; Cardiovascular Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Hippocampus; In Vitro Techniques; Membrane Potentials; Nickel; Nifedipine; Patch-Clamp Techniques; Pyramidal Cells; Pyrimidines; Rats; Rats, Wistar; Sodium Channel Blockers; Tetrodotoxin | 2008 |
Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Topics: Amlodipine; Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Chelating Agents; Chemokine CCL2; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Flavonoids; Humans; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Nifedipine; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; RNA Interference; RNA, Messenger; Time Factors; Transfection | 2010 |
Clinical case: Peritoneal dialysis patient with cloudy peritoneal fluid following administration of calcium antagonists.
Topics: Adult; Antihypertensive Agents; Ascitic Fluid; Calcium Channel Blockers; Cardiovascular Agents; Chylous Ascites; Diagnosis, Differential; Dihydropyridines; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Kidney Failure, Chronic; Nifedipine; Nitrobenzenes; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperazines; Retrospective Studies; Triglycerides | 2011 |